1-3 of 3
Richard J. Honeywell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma

Myra E. van Linde, Mariette Labots, Cyrillo G. Brahm, Koos E. Hovinga, Philip C. De Witt Hamer, Richard J. Honeywell, Richard de Goeij-de Haas, Alex A. Henneman, Jaco C. Knol, Godefridus J. Peters, Henk Dekker, Sander R. Piersma, Thang V. Pham, William P. Vandertop, Connie R. Jiménez, Henk M.W. Verheul
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (8): 1595–1602.
https://doi.org/10.1158/1078-0432.CCR-21-1933
Published: 14 April 2022
View articletitled, Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
Open the PDF for Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance

Kristy J. Gotink, Henk J. Broxterman, Mariette Labots, Richard R. de Haas, Henk Dekker, Richard J. Honeywell, Michelle A. Rudek, Laurens V. Beerepoot, René J. Musters, Gerrit Jansen, Arjan W. Griffioen, Yehuda G. Assaraf, Roberto Pili, Godefridus J. Peters, Henk M.W. Verheul
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7337–7346.
https://doi.org/10.1158/1078-0432.CCR-11-1667
Published: 30 November 2011
View articletitled, Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
Open the PDF for Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance in another window
Includes: Supplementary data
Journal Articles

A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naïve Patients with Advanced Non–Small Cell Lung Cancer

Joline S.W. Lind, Anne-Marie C. Dingemans, Harry J.M. Groen, Frederik B. Thunnissen, Otto Bekers, Daniëlle A.M. Heideman, Richard J. Honeywell, Elisa Giovannetti, Godefridus J. Peters, Pieter E. Postmus, Robert Jan van Suylen, Egbert F. Smit
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (11): 3078–3087.
https://doi.org/10.1158/1078-0432.CCR-09-3033
Published: 31 May 2010
View articletitled, A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naïve Patients with Advanced Non–Small Cell Lung Cancer
Open the PDF for A Multicenter Phase II Study of Erlotinib and Sorafenib in Chemotherapy-Naïve Patients with Advanced Non–Small Cell Lung Cancer in another window